UK-EU talks target 'win-win' outcome on vaccine supplies

25 March 2021
brexit_big

A joint statement from the UK government and the European Union signals the latest attempt to draw a line under a long-running dispute over vaccine supplies in Europe.

The UK and EU said they have been “discussing what more we can do to ensure a reciprocally beneficial relationship between the UK and EU on COVID-19.”

In February, with the vaccine rollout proceeding slowly in Europe, officials threatened to block exports from the 27-nation trading bloc, raising concerns over so-called “vaccine nationalism.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology